Publications by authors named "Osamu Morimura"

Claim this Profile
A
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLC.
Kensuke Kanaoka, Kinnosuke Matsumoto, Takayuki Shiroyama, Akihiro Tsukaguchi, Nao Shoshihara, Osamu Morimura

JTO Clin Res Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19.
Kengo Matsumoto, Tsutomu Nishida, Dai Nakamatsu, Masashi Yamamoto, Koji Fukui, Osamu Morimura

Clin Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
Kinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, Toshiyuki Minami, Yuhei Kinehara, Osamu Morimura

Cancer Immunol Immunother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal symptoms in 609 Japanese patients with COVID-19: a single-center retrospective study.
Shinji Kuriki, Tsutomu Nishida, Li-Sa Chang, Kana Hosokawa, Yoshifumi Fujii, Osamu Morimura

Scand J Gastroenterol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC.
Yuhei Kinehara, Takayuki Shiroyama, Akihiro Tamiya, Motohiro Tamiya, Seigo Minami, Osamu Morimura

JTO Clin Res Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose control in the early phase of hospitalization is associated with severe prognosis in coronavirus disease 2019 (COVID-19) patients with diabetes in Japan.
Yukiyoshi Okauchi, Ryuki Sakamoto, Tomoko Kaketaka, Eri Yamabayashi, Motohiro Kubori, Osamu Morimura

Diabetol Int· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC.
Tomoki Kuge, Takayuki Shiroyama, Akihiro Tamiya, Motohiro Tamiya, Masaki Kanazu, Osamu Morimura

JTO Clin Res Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous manifestations of coronavirus disease 2019 patients in Japan.
Masakazu Tamai, Rika Sakamoto, Noriko Goto, Osamu Morimura, Tsutomu Nishida

J Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report.
Kazumasa Soma, Tsutomu Nishida, Naoto Osugi, Osamu Morimura, Shiro Adachi

Clin J Gastroenterol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19).
Yukiyoshi Okauchi, Kanae Matsuno, Tsutomu Nishida, Koichi Sawada, Akiko Kawasaki, Osamu Morimura

Endocr J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical factors predicting the development of critical disease in Japanese patients with COVID-19: A single-center, retrospective, observational study.
Takatoshi Higuchi, Tsutomu Nishida, Hiromi Iwahashi, Osamu Morimura, Yasushi Otani

J Med Virol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest.
Hirotoshi Ishigaki, Toshiyuki Minami, Osamu Morimura, Hidemi Kitai, Daisuke Horio

Biochem Biophys Res Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-proteinase 3-positive Eosinophilic Granulomatosis with Polyangiitis Revealed by Cardiac Tamponade.
Yuji Yamamoto, Yasushi Otani, Fukuko Okabe, Midori Yoneda, Osamu Morimura

Intern Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102.
Takashi Yokoi, Seigo Minami, Takayuki Shiroyama, Taro Koba, Yoshitaro Torii, Osamu Morimura

Intern Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.
Yuhei Kinehara, Izumi Nagatomo, Shohei Koyama, Daisuke Ito, Satoshi Nojima, Osamu Morimura

JCI Insight· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Direct Oblique Method: A New Gold Standard for Bronchoscopic Navigation That is Superior to Automatic Methods.
Kotaro Miyake, Osamu Morimura, Takako Inoue, Kenya Yoshida, Izumi Nagatomo

J Bronchology Interv Pulmonol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging.
Yingji Jin, Yoshito Takeda, Yasushi Kondo, Lokesh P Tripathi, Sujin Kang, Osamu Morimura

Sci Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models.
Osamu Morimura, Toshiyuki Minami, Takashi Kijima, Shohei Koyama, Tomoyuki Otsuka

Biochem Biophys Res Commun· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas database.
Masayoshi Higashiguchi, Izumi Nagatomo, Takashi Kijima, Osamu Morimura, Kotaro Miyake

FEBS Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid.
Yuhei Kinehara, Takashi Kijima, Koji Inoue, Haruhiko Hirata, Yoshiko Takeuchi, Osamu Morimura

Intern Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.
Yuhei Kinehara, Toshiyuki Minami, Takashi Kijima, Shigenori Hoshino, Osamu Morimura

Lung Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.
Toshiyuki Minami, Takashi Kijima, Satoshi Kohmo, Hisashi Arase, Yasushi Otani, Osamu Morimura

Sci Rep· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseases.
Hidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, Norio Okamoto, Yuka Matsuura, Osamu Morimura

Mol Clin Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
Motohiro Tamiya, Masashi Kobayashi, Osamu Morimura, Tomomi Yasue, Takashi Nakasuji

Clin Lung Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients.
Hidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, Norio Okamoto, Yuka Matsuura, Osamu Morimura

Support Care Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis